- Home
- BOWN vs UG Comparison
BOWN vs UG Comparison
Compare BOWN & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOWN
- UG
- Stock Information
- Founded
- BOWN 2023
- UG 1942
- Country
- BOWN United States
- UG United States
- Employees
- BOWN N/A
- UG N/A
- Industry
- BOWN
- UG Package Goods/Cosmetics
- Sector
- BOWN
- UG Consumer Discretionary
- Exchange
- BOWN Nasdaq
- UG Nasdaq
- Market Cap
- BOWN 32.8M
- UG 36.9M
- IPO Year
- BOWN 2023
- UG N/A
- Fundamental
- Price
- BOWN $8.70
- UG $8.30
- Analyst Decision
- BOWN
- UG
- Analyst Count
- BOWN 0
- UG 0
- Target Price
- BOWN N/A
- UG N/A
- AVG Volume (30 Days)
- BOWN 1.6K
- UG 3.4K
- Earning Date
- BOWN 01-01-0001
- UG 08-08-2025
- Dividend Yield
- BOWN N/A
- UG 8.53%
- EPS Growth
- BOWN N/A
- UG 4.93
- EPS
- BOWN 0.32
- UG 0.63
- Revenue
- BOWN N/A
- UG $11,408,154.00
- Revenue This Year
- BOWN N/A
- UG N/A
- Revenue Next Year
- BOWN N/A
- UG N/A
- P/E Ratio
- BOWN $31.11
- UG $13.29
- Revenue Growth
- BOWN N/A
- UG N/A
- 52 Week Low
- BOWN $2.71
- UG $7.73
- 52 Week High
- BOWN $19.77
- UG $16.25
- Technical
- Relative Strength Index (RSI)
- BOWN 30.31
- UG 51.30
- Support Level
- BOWN $10.50
- UG $8.10
- Resistance Level
- BOWN $10.90
- UG $8.35
- Average True Range (ATR)
- BOWN 0.36
- UG 0.18
- MACD
- BOWN -0.21
- UG 0.01
- Stochastic Oscillator
- BOWN 9.48
- UG 56.52
About BOWN Bowen Acquisition Corp
Bowen Acquisition Corp is a blank check company.
About UG United-Guardian Inc.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.